A detailed history of Valley National Advisers Inc transactions in Viatris Inc stock. As of the latest transaction made, Valley National Advisers Inc holds 1,315 shares of VTRS stock, worth $15,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,315
Previous 1,615 18.58%
Holding current value
$15,109
Previous $19,000 31.58%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$10.05 - $12.02 $3,015 - $3,606
-300 Reduced 18.58%
1,315 $13,000
Q1 2024

Apr 19, 2024

SELL
$11.27 - $13.53 $1,284 - $1,542
-114 Reduced 6.59%
1,615 $19,000
Q4 2023

Jan 25, 2024

SELL
$8.77 - $10.85 $4,455 - $5,511
-508 Reduced 22.71%
1,729 $18,000
Q3 2023

Nov 13, 2023

BUY
$9.59 - $11.35 $1,217 - $1,441
127 Added 6.02%
2,237 $22,000
Q2 2023

Jul 31, 2023

BUY
$9.02 - $10.29 $54 - $61
6 Added 0.29%
2,110 $22,000
Q1 2023

Apr 26, 2023

SELL
$9.2 - $12.26 $2,309 - $3,077
-251 Reduced 10.66%
2,104 $20,000
Q4 2022

Jan 12, 2023

SELL
$8.72 - $11.56 $104 - $138
-12 Reduced 0.51%
2,355 $27,000
Q3 2022

Nov 08, 2022

SELL
$8.48 - $11.13 $2,382 - $3,127
-281 Reduced 10.61%
2,367 $23,000
Q2 2022

Jul 15, 2022

SELL
$9.95 - $12.27 $3,114 - $3,840
-313 Reduced 10.57%
2,648 $28,000
Q1 2022

May 06, 2022

SELL
$9.81 - $15.4 $84,473 - $132,609
-8,611 Reduced 74.41%
2,961 $33,000
Q4 2021

Feb 11, 2022

BUY
$12.09 - $14.68 $44,213 - $53,684
3,657 Added 46.2%
11,572 $157,000
Q3 2021

Nov 10, 2021

SELL
$13.25 - $15.13 $516 - $590
-39 Reduced 0.49%
7,915 $107,000
Q2 2021

Aug 02, 2021

SELL
$12.97 - $16.15 $985 - $1,227
-76 Reduced 0.95%
7,954 $114,000
Q1 2021

May 07, 2021

SELL
$13.59 - $18.54 $2,731 - $3,726
-201 Reduced 2.44%
8,030 $112,000
Q4 2020

Feb 11, 2021

BUY
$14.3 - $18.74 $117,703 - $154,248
8,231 New
8,231 $154,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.